• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Hydroxyindoles

Recent Advances in the Study of 4-Nitro-1H-indol-6-ol (CAS: 885520-63-8): A Promising Compound in Chemical Biology and Pharmaceutical Research

The compound 4-Nitro-1H-indol-6-ol (CAS: 885520-63-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 4-Nitro-1H-indol-6-ol as a key intermediate in the synthesis of various bioactive molecules. Its nitro and hydroxyl functional groups make it a versatile building block for the development of novel pharmaceuticals. Researchers have explored its utility in the synthesis of indole-based compounds, which are known for their diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer properties.

One of the most notable advancements in the study of 4-Nitro-1H-indol-6-ol is its potential application in cancer therapy. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory effects on certain cancer cell lines, particularly those associated with breast and prostate cancers. The study utilized advanced computational modeling and in vitro assays to elucidate the mechanism of action, revealing that these derivatives target specific signaling pathways involved in tumor proliferation.

In addition to its anticancer properties, 4-Nitro-1H-indol-6-ol has also been investigated for its antimicrobial potential. A recent study in the European Journal of Medicinal Chemistry reported that this compound, when modified with specific substituents, shows significant activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). This finding underscores the compound's potential as a lead structure for the development of new antibiotics.

The synthesis of 4-Nitro-1H-indol-6-ol has also seen advancements, with researchers developing more efficient and environmentally friendly methods. A 2022 publication in Organic Letters described a novel catalytic approach that reduces the need for hazardous reagents and improves yield. This method not only enhances the scalability of production but also aligns with the growing demand for sustainable chemical processes in the pharmaceutical industry.

Despite these promising developments, challenges remain in the clinical translation of 4-Nitro-1H-indol-6-ol-based therapeutics. Issues such as bioavailability, toxicity, and metabolic stability need to be addressed through further research. However, the compound's versatility and the recent progress in its study suggest that it holds considerable promise for future drug discovery efforts.

In conclusion, 4-Nitro-1H-indol-6-ol (CAS: 885520-63-8) represents a valuable scaffold in chemical biology and pharmaceutical research. Its diverse biological activities and the recent advancements in its synthesis and application highlight its potential as a key player in the development of next-generation therapeutics. Continued research in this area is expected to yield further insights and innovations, paving the way for new treatments in oncology, infectious diseases, and beyond.

• 57905-76-7(4-Nitro-9H-carbazole)
• 175913-41-4(4-methoxy-6-nitro-1H-indole)
• 64670-84-4(Acridine, 1-nitro-9-phenoxy-)
• 6270-14-0(4-hydroxy-7-nitroquinoline)
• 4008-48-4(Nitroxoline)
• 4769-97-5(4-nitro-1H-indole)
• 188970-86-7(7H-Dibenzo[c,g]carbazol-2-ol,5-nitro-)
• 188970-78-7(7H-Dibenzo[c,g]carbazole,5-nitro-)
• 153654-33-2(9H-Carbazol-2-ol,3-nitro-)
• 188970-84-5(7H-Dibenzo[c,g]carbazol-4-ol,9-nitro-)